Massachusetts Financial Services CO 10x Genomics, Inc. Transaction History

Massachusetts Financial Services CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$126.47 - $163.7 $11.5 Million - $14.9 Million	-91,278 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$87.44 - $125.0 $3.75 Million - $5.37 Million	-42,930 Reduced 31.99%	91,278 $11.4 Million
Q2 2020 Aug 11, 2020	BUY	$58.39 - $89.31 $636,859 - $974,104	10,907 Added 8.85%	134,208 $12 Million
Q1 2020 May 14, 2020	SELL	$51.57 - $106.62 $1.39 Million - $2.87 Million	-26,955 Reduced 17.94%	123,301 $7.68 Million
Q4 2019 Feb 13, 2020	SELL	$46.07 - $79.54 $533,951 - $921,868	-11,590 Reduced 7.16%	150,256 $11.5 Million
Q3 2019 Nov 05, 2019	BUY	$49.99 - $62.0 $8.09 Million - $10 Million	161,846 New	161,846 $8.16 Million

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.